| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 32,952 | 29,721 | 24,394 | 30,732 | | Cost of Revenue | 22,416 | 21,193 | 15,731 | 20,785 | | | Gross Profit | 10,536 | 8,528 | 8,663 | 9,947 | | | Operating Expenses | | Research Development | 4,046 | 4,117 | 3,996 | 4,363 | | Selling General and Administrative | 6,828 | 5,343 | 5,136 | 5,453 | | Non Recurring |
-
| 74 | 293 | 217 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (338) | (1,006) | (762) | (86) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,643 | 1,742 | 1,453 | 1,264 | | Earnings Before Interest And Taxes | 1,305 | 736 | 691 | 1,178 | | Interest Expense |
-
| 65 |
-
|
-
| | Income Before Tax | 1,305 | 671 | 691 | 1,178 | | Income Tax Expense | 475 | (135) | 460 | (46) | | Minority Interest | (22) | (22) | (24) | (23) | | | | Net Income From Continuing Ops | 830 | 1,040 | 256 | 1,130 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,335 | 1,040 | 256 | 1,130 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,335 | $1,040 | $256 | $1,130 |
|
0.02% Nasdaq 0.00%
Income Statement
